+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Molecular Transport Medium Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • PDF Icon

    Report

  • 280 Pages
  • June 2025
  • Region: Global
  • Fairfield Market Research
  • ID: 5916020
The global molecular transport medium market is set to witness moderate growth over the forecast period 2025-2032, according to a new report. The market is anticipated to expand from an estimated US$ 1.06 billion in 2025 to US$ 1.2 billion by 2032, progressing at a CAGR of 1.79%. This growth is supported by increasing demand for safe and effective specimen transportation solutions across diagnostic laboratories and healthcare facilities globally.

Market Insights

Molecular transport mediums are critical for safely collecting, storing, and transporting biological samples, including viruses and bacteria, to diagnostic laboratories. They play a vital role in the management of infectious disease outbreaks, particularly in pandemics such as COVID-19. Although the market experienced a dip following the pandemic peak, the long-term outlook remains positive due to ongoing testing needs and healthcare advancements.

The market holds a significant share in the broader swab and viral transport medium industry and is evolving with growing awareness regarding disease prevention, especially in regions with increasing healthcare investments.

Key Market Drivers

One of the primary drivers of the molecular transport medium market is the heightened need for safe and reliable transport of infectious samples, especially during pandemic outbreaks. Global health agencies emphasize the importance of molecular transport mediums to ensure biosafety during sample collection and analysis.

Technological advancements have led to the development of non-hazardous and leak-proof formulations, further improving sample stability and reducing risks of contamination. These innovations are transforming conventional practices, making molecular transport mediums more viable and efficient.

Additionally, rising public awareness about infectious diseases, government support for diagnostic infrastructure, and the emphasis on early detection of diseases are fueling market expansion.

Business Opportunity

Manufacturers have the opportunity to leverage R&D and innovate products that offer improved sample integrity and longer stability across varying temperatures. Enhanced formulations that prevent degradation during transportation, especially in resource-limited settings, are highly sought after.

Companies that invest in local production capabilities, especially in emerging economies, stand to benefit from supply chain efficiencies and reduced import dependency. There is also significant potential for partnerships with healthcare institutions to co-develop tailor-made transport solutions that align with regional needs.

Regional Analysis

North America continues to lead the molecular transport medium market, driven by strong healthcare infrastructure and high awareness levels. The U.S., in particular, represents a lucrative market due to the presence of leading players and robust disease monitoring systems.

In Europe, Germany is gaining traction due to recent launches of viral inactivation media, aiding in the safe collection and transport of infectious specimens. Regulatory compliance and innovation are key factors supporting market development in this region.

Asia is emerging as a hotspot for growth, with China and India leading the charge. China’s significant investments in research and diagnostic infrastructure are driving demand. India is witnessing strong momentum as local firms develop cost-effective solutions for long-term storage and safe sample transportation. The launch of indigenous products like mWRAPR highlights India’s self-reliance drive in diagnostic tools.

Key Players

The market is moderately fragmented, with both established companies and emerging players contributing to technological innovation and capacity expansion. Key participants in the global molecular transport medium market include:
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson, and Company
  • Cardinal Health
  • Quidel Corporation
  • Medical Wire & Equipment
  • COPAN Diagnostics Inc.
  • Titan Biotech Ltd.
  • Alpha Teknova, Inc.
  • Bio-Genex Laboratories Inc.
  • EKF Diagnostics
  • Trinity Biotech
  • Alpha-Tec Systems, Inc.
  • Charm Sciences, Inc.
  • Azer Scientific
  • bioBoaVista
  • AccuGene
  • KSL Diagnostics
  • Puritan Medical Products
  • Amazing Biotech (Shanghai) Co., Ltd.
These players focus on strategies such as expansion of production capacity, new product launches, and regional penetration to gain a competitive edge.

Market Segmentation

By Product Type:

  • Active Transport Medium
  • Inactivated Transport Medium

By Application:

  • Virus (COVID-19, MERS, Influenza, HIV, Rhinovirus, Adenovirus, RSV)
  • Bacteria (Staphylococcus Pneumonia, Haemophilus Influenza, Anthrax)
  • Atypical Bacteria (Mycoplasma, Q-Fever, Others)
  • Mycobacterial and Fungal Infections

By Sample:

  • Nasal Washes and Swabs
  • Sputum
  • Saliva
  • Faecal & Stool
  • Urine
  • Blood
  • Tissues
  • Others

By End User:

  • Diagnostic Laboratories
  • Microbiology Laboratories
  • Hospitals & Clinics
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East & Africa

This product will be delivered within 1-3 business days.

Table of Contents

1. Executive Summary
1.1. Global Molecular Transport Medium Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2025
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Molecular Transport Medium Market Outlook, 2019-2032
3.1. Global Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
3.1.1. Key Highlights
3.1.1.1. Active Transport Medium
3.1.1.2. Inactivated Transport Medium
3.2. Global Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2019-2032
3.2.1. Key Highlights
3.2.1.1. Virus
3.2.1.1.1. COVID-19
3.2.1.1.2. Middle East Respiratory Syndrome (MERS)
3.2.1.1.3. Influenza
3.2.1.1.4. Human Immunodeficiency Virus (HIV)
3.2.1.1.5. Rhinovirus
3.2.1.1.6. Adenovirus
3.2.1.1.7. Respiratory Syncytial Virus (RSV)
3.2.1.2. Bacteria
3.2.1.2.1. Staphylococcus Pneumonia
3.2.1.2.2. Haemophilus Influenza
3.2.1.2.3. Anthrax
3.2.1.2.4. Others
3.2.1.3. Atypical Bacteria
3.2.1.3.1. Mycoplasma
3.2.1.3.2. Q-Fever
3.2.1.3.3. Others
3.2.1.4. Mycobacterial and Fungal Infection
3.3. Global Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2019-2032
3.3.1. Key Highlights
3.3.1.1. Nasal Washes and Swabs
3.3.1.2. Sputum
3.3.1.3. Saliva
3.3.1.4. Faecal & Stool
3.3.1.5. Urine
3.3.1.6. Blood
3.3.1.7. Tissues
3.3.1.8. Others
3.4. Global Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2019-2032
3.4.1. Key Highlights
3.4.1.1. Diagnostic Laboratories
3.4.1.2. Microbiology Laboratories
3.4.1.3. Hospitals & Clinics
3.4.1.4. Others
3.5. Global Molecular Transport Medium Market Outlook, by Region, Value (US$ Bn), 2019-2032
3.5.1. Key Highlights
3.5.1.1. North America
3.5.1.2. Europe
3.5.1.3. Asia Pacific
3.5.1.4. Latin America
3.5.1.5. Middle East & Africa
4. North America Molecular Transport Medium Market Outlook, 2019-2032
4.1. North America Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
4.1.1. Key Highlights
4.1.1.1. Active Transport Medium
4.1.1.2. Inactivated Transport Medium
4.2. North America Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2019-2032
4.2.1. Key Highlights
4.2.1.1. Virus
4.2.1.1.1. COVID-19
4.2.1.1.2. Middle East Respiratory Syndrome (MERS)
4.2.1.1.3. Influenza
4.2.1.1.4. Human Immunodeficiency Virus (HIV)
4.2.1.1.5. Rhinovirus
4.2.1.1.6. Adenovirus
4.2.1.1.7. Respiratory Syncytial Virus (RSV)
4.2.1.2. Bacteria
4.2.1.2.1. Staphylococcus Pneumonia
4.2.1.2.2. Haemophilus Influenza
4.2.1.2.3. Anthrax
4.2.1.2.4. Others
4.2.1.3. Atypical Bacteria
4.2.1.3.1. Mycoplasma
4.2.1.3.2. Q-Fever
4.2.1.3.3. Others
4.2.1.4. Mycobacterial and Fungal Infection
4.3. North America Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2019-2032
4.3.1. Key Highlights
4.3.1.1. Nasal Washes and Swabs
4.3.1.2. Sputum
4.3.1.3. Saliva
4.3.1.4. Faecal & Stool
4.3.1.5. Urine
4.3.1.6. Blood
4.3.1.7. Tissues
4.3.1.8. Others
4.4. North America Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2019-2032
4.4.1. Key Highlights
4.4.1.1. Diagnostic Laboratories
4.4.1.2. Microbiology Laboratories
4.4.1.3. Hospitals & Clinics
4.4.1.4. Others
4.5. North America Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2019-2032
4.5.1. Key Highlights
4.5.1.1. U.S. Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
4.5.1.2. U.S. Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
4.5.1.3. U.S. Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
4.5.1.4. U.S. Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
4.5.1.5. Canada Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
4.5.1.6. Canada Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
4.5.1.7. Canada Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
4.5.1.8. Canada Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
4.5.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Molecular Transport Medium Market Outlook, 2019-2032
5.1. Europe Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
5.1.1. Key Highlights
5.1.1.1. Active Transport Medium
5.1.1.2. Inactivated Transport Medium
5.2. Europe Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2019-2032
5.2.1. Key Highlights
5.2.1.1. Virus
5.2.1.1.1. COVID-19
5.2.1.1.2. Middle East Respiratory Syndrome (MERS)
5.2.1.1.3. Influenza
5.2.1.1.4. Human Immunodeficiency Virus (HIV)
5.2.1.1.5. Rhinovirus
5.2.1.1.6. Adenovirus
5.2.1.1.7. Respiratory Syncytial Virus (RSV)
5.2.1.2. Bacteria
5.2.1.2.1. Staphylococcus Pneumonia
5.2.1.2.2. Haemophilus Influenza
5.2.1.2.3. Anthrax
5.2.1.2.4. Others
5.2.1.3. Atypical Bacteria
5.2.1.3.1. Mycoplasma
5.2.1.3.2. Q-Fever
5.2.1.3.3. Others
5.2.1.4. Mycobacterial and Fungal Infection
5.3. Europe Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2019-2032
5.3.1. Key Highlights
5.3.1.1. Nasal Washes and Swabs
5.3.1.2. Sputum
5.3.1.3. Saliva
5.3.1.4. Faecal & Stool
5.3.1.5. Urine
5.3.1.6. Blood
5.3.1.7. Tissues
5.3.1.8. Others
5.4. Europe Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2019-2032
5.4.1. Key Highlights
5.4.1.1. Diagnostic Laboratories
5.4.1.2. Microbiology Laboratories
5.4.1.3. Hospitals & Clinics
5.4.1.4. Others
5.5. Europe Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2019-2032
5.5.1. Key Highlights
5.5.1.1. Germany Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
5.5.1.2. Germany Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
5.5.1.3. Germany Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
5.5.1.4. Germany Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
5.5.1.5. U.K. Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
5.5.1.6. U.K. Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
5.5.1.7. U.K. Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
5.5.1.8. U.K. Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
5.5.1.9. France Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
5.5.1.10. France Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
5.5.1.11. France Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
5.5.1.12. France Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
5.5.1.13. Italy Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
5.5.1.14. Italy Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
5.5.1.15. Italy Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
5.5.1.16. Italy Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
5.5.1.17. Turkey Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
5.5.1.18. Turkey Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
5.5.1.19. Turkey Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
5.5.1.20. Turkey Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
5.5.1.21. Russia Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
5.5.1.22. Russia Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
5.5.1.23. Russia Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
5.5.1.24. Russia Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
5.5.1.25. Rest of Europe Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
5.5.1.26. Rest of Europe Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
5.5.1.27. Rest of Europe Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
5.5.1.28. Rest of Europe Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
5.5.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Molecular Transport Medium Market Outlook, 2019-2032
6.1. Asia Pacific Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
6.1.1. Key Highlights
6.1.1.1. Active Transport Medium
6.1.1.2. Inactivated Transport Medium
6.2. Asia Pacific Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2019-2032
6.2.1. Key Highlights
6.2.1.1. Virus
6.2.1.1.1. COVID-19
6.2.1.1.2. Middle East Respiratory Syndrome (MERS)
6.2.1.1.3. Influenza
6.2.1.1.4. Human Immunodeficiency Virus (HIV)
6.2.1.1.5. Rhinovirus
6.2.1.1.6. Adenovirus
6.2.1.1.7. Respiratory Syncytial Virus (RSV)
6.2.1.2. Bacteria
6.2.1.2.1. Staphylococcus Pneumonia
6.2.1.2.2. Haemophilus Influenza
6.2.1.2.3. Anthrax
6.2.1.2.4. Others
6.2.1.3. Atypical Bacteria
6.2.1.3.1. Mycoplasma
6.2.1.3.2. Q-Fever
6.2.1.3.3. Others
6.2.1.4. Mycobacterial and Fungal Infection
6.3. Asia Pacific Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2019-2032
6.3.1. Key Highlights
6.3.1.1. Nasal Washes and Swabs
6.3.1.2. Sputum
6.3.1.3. Saliva
6.3.1.4. Faecal & Stool
6.3.1.5. Urine
6.3.1.6. Blood
6.3.1.7. Tissues
6.3.1.8. Others
6.4. Asia Pacific Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2019-2032
6.4.1. Key Highlights
6.4.1.1. Diagnostic Laboratories
6.4.1.2. Microbiology Laboratories
6.4.1.3. Hospitals & Clinics
6.4.1.4. Others
6.5. Asia Pacific Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2019-2032
6.5.1. Key Highlights
6.5.1.1. China Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
6.5.1.2. China Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
6.5.1.3. China Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
6.5.1.4. China Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
6.5.1.5. Japan Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
6.5.1.6. Japan Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
6.5.1.7. Japan Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
6.5.1.8. Japan Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
6.5.1.9. South Korea Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
6.5.1.10. South Korea Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
6.5.1.11. South Korea Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
6.5.1.12. South Korea Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
6.5.1.13. India Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
6.5.1.14. India Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
6.5.1.15. India Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
6.5.1.16. India Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
6.5.1.17. Southeast Asia Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
6.5.1.18. Southeast Asia Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
6.5.1.19. Southeast Asia Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
6.5.1.20. Southeast Asia Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
6.5.1.21. Rest of Asia Pacific Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
6.5.1.22. Rest of Asia Pacific Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
6.5.1.23. Rest of Asia Pacific Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
6.5.1.24. Rest of Asia Pacific Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
6.5.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Molecular Transport Medium Market Outlook, 2019-2032
7.1. Latin America Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
7.1.1. Key Highlights
7.1.1.1. Active Transport Medium
7.1.1.2. Inactivated Transport Medium
7.2. Latin America Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2019-2032
7.2.1.1. Virus
7.2.1.1.1. COVID-19
7.2.1.1.2. Middle East Respiratory Syndrome (MERS)
7.2.1.1.3. Influenza
7.2.1.1.4. Human Immunodeficiency Virus (HIV)
7.2.1.1.5. Rhinovirus
7.2.1.1.6. Adenovirus
7.2.1.1.7. Respiratory Syncytial Virus (RSV)
7.2.1.2. Bacteria
7.2.1.2.1. Staphylococcus Pneumonia
7.2.1.2.2. Haemophilus Influenza
7.2.1.2.3. Anthrax
7.2.1.2.4. Others
7.2.1.3. Atypical Bacteria
7.2.1.3.1. Mycoplasma
7.2.1.3.2. Q-Fever
7.2.1.3.3. Others
7.2.1.4. Mycobacterial and Fungal Infection
7.3. Latin America Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2019-2032
7.3.1. Key Highlights
7.3.1.1. Nasal Washes and Swabs
7.3.1.2. Sputum
7.3.1.3. Saliva
7.3.1.4. Faecal & Stool
7.3.1.5. Urine
7.3.1.6. Blood
7.3.1.7. Tissues
7.3.1.8. Others
7.4. Latin America Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2019-2032
7.4.1. Key Highlights
7.4.1.1. Diagnostic Laboratories
7.4.1.2. Microbiology Laboratories
7.4.1.3. Hospitals & Clinics
7.4.1.4. Others
7.5. Latin America Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2019-2032
7.5.1. Key Highlights
7.5.1.1. Brazil Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
7.5.1.2. Brazil Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
7.5.1.3. Brazil Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
7.5.1.4. Brazil Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
7.5.1.5. Mexico Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
7.5.1.6. Mexico Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
7.5.1.7. Mexico Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
7.5.1.8. Mexico Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
7.5.1.9. Argentina Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
7.5.1.10. Argentina Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
7.5.1.11. Argentina Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
7.5.1.12. Argentina Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
7.5.1.13. Rest of Latin America Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
7.5.1.14. Rest of Latin America Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
7.5.1.15. Rest of Latin America Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
7.5.1.16. Rest of Latin America Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
7.5.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Molecular Transport Medium Market Outlook, 2019-2032
8.1. Middle East & Africa Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2019-2032
8.1.1. Key Highlights
8.1.1.1. Active Transport Medium
8.1.1.2. Inactivated Transport Medium
8.2. Middle East & Africa Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2019-2032
8.2.1. Key Highlights
8.2.1.1. v
8.3. Middle East & Africa Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2019-2032
8.3.1. Key Highlights
8.3.1.1. Nasal Washes and Swabs
8.3.1.2. Sputum
8.3.1.3. Saliva
8.3.1.4. Faecal & Stool
8.3.1.5. Urine
8.3.1.6. Blood
8.3.1.7. Tissues
8.3.1.8. Others
8.4. Middle East & Africa Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2019-2032
8.4.1. Key Highlights
8.4.1.1. Diagnostic Laboratories
8.4.1.2. Microbiology Laboratories
8.4.1.3. Hospitals & Clinics
8.4.1.4. Others
8.5. Middle East & Africa Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2019-2032
8.5.1. Key Highlights
8.5.1.1. GCC Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
8.5.1.2. GCC Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
8.5.1.3. GCC Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
8.5.1.4. GCC Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
8.5.1.5. South Africa Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
8.5.1.6. South Africa Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
8.5.1.7. South Africa Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
8.5.1.8. South Africa Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
8.5.1.9. Egypt Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
8.5.1.10. Egypt Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
8.5.1.11. Egypt Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
8.5.1.12. Egypt Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
8.5.1.13. Nigeria Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
8.5.1.14. Nigeria Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
8.5.1.15. Nigeria Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
8.5.1.16. Nigeria Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
8.5.1.17. Rest of Middle East & Africa Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2019-2032
8.5.1.18. Rest of Middle East & Africa Molecular Transport Medium Market By Application, Value (US$ Bn), 2019-2032
8.5.1.19. Rest of Middle East & Africa Molecular Transport Medium Market By Sample, Value (US$ Bn), 2019-2032
8.5.1.20. Rest of Middle East & Africa Molecular Transport Medium Market By End User, Value (US$ Bn), 2019-2032
8.5.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. By Sample vs By Application Heatmap
9.2. Manufacturer vs By Application Heatmap
9.3. Company Market Share Analysis, 2025
9.4. Competitive Dashboard
9.5. Company Profiles
9.5.1. Thermo Fisher Scientific Inc.
9.5.1.1. Company Overview
9.5.1.2. Product Portfolio
9.5.1.3. Financial Overview
9.5.1.4. Business Strategies and Development
9.5.2. Becton, Dickinson, and Company
9.5.2.1. Company Overview
9.5.2.2. Product Portfolio
9.5.2.3. Financial Overview
9.5.2.4. Business Strategies and Development
9.5.3. Cardinal Health
9.5.3.1. Company Overview
9.5.3.2. Product Portfolio
9.5.3.3. Financial Overview
9.5.3.4. Business Strategies and Development
9.5.4. Quidel Corporation
9.5.4.1. Company Overview
9.5.4.2. Product Portfolio
9.5.4.3. Financial Overview
9.5.4.4. Business Strategies and Development
9.5.5. Medical Wire & Equipment
9.5.5.1. Company Overview
9.5.5.2. Product Portfolio
9.5.5.3. Financial Overview
9.5.5.4. Business Strategies and Development
9.5.6. COPAN Diagnostics Inc.
9.5.6.1. Company Overview
9.5.6.2. Product Portfolio
9.5.6.3. Financial Overview
9.5.6.4. Business Strategies and Development
9.5.7. Titan Biotech Ltd.
9.5.7.1. Company Overview
9.5.7.2. Product Portfolio
9.5.7.3. Financial Overview
9.5.7.4. Business Strategies and Development
9.5.8. Alpha Teknova, Inc. [former named Teknova]
9.5.8.1. Company Overview
9.5.8.2. Product Portfolio
9.5.8.3. Financial Overview
9.5.8.4. Business Strategies and Development
9.5.9. Bio-Genex Laboratories Inc.
9.5.9.1. Company Overview
9.5.9.2. Product Portfolio
9.5.9.3. Financial Overview
9.5.9.4. Business Strategies and Development
9.5.10. EKF Diagnostics
9.5.10.1. Company Overview
9.5.10.2. Product Portfolio
9.5.10.3. Financial Overview
9.5.10.4. Business Strategies and Development
10. Appendix
10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations

Companies Mentioned

  • Thermo Fisher Scientific
  • Becton Dickinson and Company
  • Cardinal Health
  • Quidel Corporation
  • Medical Wire & Equipment (MWE)
  • COPAN Diagnostics Inc. [COPAN Group]
  • Titan Biotech Ltd.
  • Alpha Teknova, Inc. [formerly named Teknova]
  • Bio-Genex Laboratories Inc.
  • EKF Diagnostics
  • Trinity Biotech
  • Alpha-Tec Systems, Inc.
  • Charm Sciences, Inc.
  • Azer Scientific
  • bioBoaVista
  • AccuGene
  • KSL Diagnostics
  • Puritan Medical Products
  • Amazing Biotech (Shanghai) Co., Ltd